<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Loss-of-function <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:e sem="disease" ids="C1720983" disease_type="Disease or Syndrome" abbrv="">channelopathies</z:e> manifest as a spectrum of diseases including <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndrome</z:e> (BrS) and cardiac conduction disease </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To analyze the diagnostic and therapeutic aspects of these disorders in children </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Patients aged ≤ 16 years with genetically confirmed loss-of-function <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:e sem="disease" ids="C1720983" disease_type="Disease or Syndrome" abbrv="">channelopathies</z:e> (SCN5A mutation), presenting with cardiac symptoms, positive family history, and/or <z:hpo ids='HP_0011675'>abnormal electrocardiogram</z:hpo> (ECG), were included </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0010508'>Abnormal ECG</z:mp> consisted of type 1 BrS ECG and/or prolonged conduction intervals (PR interval/QRS duration &gt; 98th percentile for age) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among the cohort (n = 33, age 6 ± 5 years, 58% male subjects, 30% probands), 14 (42%) patients were symptomatic, presenting with <z:hpo ids='HP_0001279'>syncope</z:hpo> (n = 5), <z:hpo ids='HP_0001962'>palpitations</z:hpo> (n = 1), <z:hpo ids='HP_0005115'>supraventricular arrhythmias</z:hpo> (n = 3), aborted <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> (n = 3), and <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> (n = 2) </plain></SENT>
<SENT sid="5" pm="."><plain>Heart rate was 91 ± 26 beats/min, PR interval 168 ± 35 ms, QRS duration 112 ± 20 ms, and heart-rate corrected QT interval 409 ± 26 ms </plain></SENT>
<SENT sid="6" pm="."><plain>Conduction intervals were prolonged in 28 (85%) patients; 6 of these patients also had spontaneous type 1 BrS ECG </plain></SENT>
<SENT sid="7" pm="."><plain>Eight <z:hpo ids='HP_0001945'>fever</z:hpo>-associated events occurred in 6 patients; 2 of these were vaccination-related <z:hpo ids='HP_0001945'>fever</z:hpo> episodes </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment included aggressive <z:chebi fb="0" ids="35493">antipyretics</z:chebi> during <z:hpo ids='HP_0001945'>fever</z:hpo> in <z:hpo ids='HP_0000001'>all</z:hpo> patients; antiarrhythmic treatment included implantable cardioverter-defibrillator (n = 4), pacemaker (n = 2), and beta-blockers, either alone (n = 3) or in combination with device (n = 2) </plain></SENT>
<SENT sid="9" pm="."><plain>During follow-up (4 ± 4 years), 2 previously symptomatic patients had monomorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>; there were no <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Diagnosis of loss-of-function <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:e sem="disease" ids="C1720983" disease_type="Disease or Syndrome" abbrv="">channelopathies</z:e> in children relies on cardiac symptoms, family history, and ECG </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0001945'>Fever</z:hpo> and vaccination are potential <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> triggers; conduction delay is the commonest finding on ECG </plain></SENT>
<SENT sid="12" pm="."><plain>Beta-blockers have a role in preventing <z:hpo ids='HP_0001649'>tachycardia</z:hpo>-induced <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>; implantable cardioverter-defibrillator should probably be reserved for severe cases </plain></SENT>
</text></document>